Public Submission Instructions

Abstract Submission

Known as Europe’s Home of Neurology, the EAN hosts one of the largest neurology forums in the region – and this year promises to be even more special.

It is our pleasure to welcome you to connect, share insights and be inspired among an audience deeply passionate about neurological discovery.

This year's event is the ideal opportunity for you to present your groundbreaking research through an oral presentation with our dedicated community.

Join us in Geneva and be part of something impactful!

Important points to remember

  1. Make sure you have an up-to-date MyEAN profile (click here to log in or create an account).
  2. Check the dates, guidelines, and topics.
  3. Abstracts must be submitted online via the congress website.
  4. If your abstract is accepted, make sure the presenting author is registered for the congress.
  5. The bursary and tournament opportunities are not available for late-breaking abstract submissions.

Important Dates

Public Abstract Submission Opening Monday 10 November 2025
Public Abstract Submission Deadline Thursday 15 January 2026
Public Abstract Review Mid-February 2026
Notification of Acceptance/Rejection Mid-March 2026
Presenting Author Registration Deadline Wednesday 22 April 2026
Late-breaking Abstract Submission Opening Thursday 9 April 2026
Presentation Upload Opening Mid-May 2026
Late-breaking Abstract Submission Deadline Wednesday 27 May 2026
Notification of Late-Breaking Acceptance/Rejection Beginning-June 2026
Presentation Upload Deadline Mid-June 2026
Lift of Abstract Embargo Friday 26 June 2026 18:30 CEST
EAN 2026 Congress Saturday 27 June - Tuesday 30 June 2026

Embargo Policy

The embargo on all abstracts will be lifted officially on Friday, 26 June 2026, 18:30 CEST. This is when the European Journal of Neurology including all Abstracts will be released on the EAN Website.

EAN 2026: Guidelines for Abstract Submission

  • Abstracts must be submitted via an active MyEAN profile. Abstracts submitted via email will not be accepted.
     
  • All co-authors' affiliations must be stated during the abstract submission. By completing the abstract submission, submitters give full consent on behalf of all co-authors to provide their data.
     
  • Abstracts must be submitted and presented in English. Proofread your abstract before submission. Ensure that your abstract does not contain spelling, grammatical or scientific errors, as it will be reproduced as submitted.
     
  • Abstracts must contain new and original information not published elsewhere prior to 26 June 2026, 18:30 CEST.
     
  • Authors must only specify oral presentation type during the late-breaking abstract submission.
  • Abstracts must be structured under the given headings:
    • Introduction - State specific objective of study
    • Methods
    • Results
    • Conclusion
    • Disclosures - In the interest of transparency, disclose all relationships/activities/interests related to your manuscript
       
  • Abstract titles may contain a maximum of 25 words and 150 characters. Abstract text (Introduction, Methods, Results and Conclusion) cannot exceed 250 words in total and 1500 characters per section.
     
  • All abbreviations used must be written out at first use.
     
  • Simplify complex mathematical formulas. Avoid symbols (Greek, mathematical, etc.). E.g. Instead of IFN-ß, use IFN-beta; instead of 10², use 10^2; instead of x≥2, use x>=2.
     
  • A maximum of 3 images can be inserted per abstract. Images can only be submitted in JPG, JPEG or PNG format. The maximum size of all figures/tables is 10 MB. EAN may adjust tables or figures to fit for final publication. Tables must be submitted as a separate graphic file. Tables and images do not affect word count.
     
  • If your research has been granted any commercial or institutional support, you will be asked to list these under Disclosures in the submission process. Prepare a one-sentence statement for this purpose. Disclosure text may contain a maximum of 3000 characters.
  • To correct a submitted abstract, email abstracts(at)ean.org with the abstract ID (A-##-#####). Abstracts that are submitted or under review cannot be edited on the submission platform. After the final submission deadline has passed, submitters can no longer modify the content, and the abstract will be published exactly as submitted.
     
  • The bursary and tournaments options are not available for late-breaking abstract submissions. During the standard abstract submission, the bursary and tournament (basic or clinical research) application options are available only if the indicated presenting author is an active Resident and Research Member (RRFS) or Student Member at EAN. 
     
  • Presenting authors must have active MyEAN accounts under the submitted email address. Every presenting author can present a maximum of 3 abstracts. The submission system will alert the submitter if the selected presenting author has already been assigned 3 abstracts. 
     
  • Within 1 hour of submission, the submitter will receive a confirmation email with a unique abstract ID. If you have not received a submission confirmation email, email abstracts(at)ean.org. The submitter is responsible for informing all authors about the abstract submission and review status. In the submission system, “Stage” is the stage of submission, and “Status” is the status of abstract review. Make sure to include the abstract ID in all communications with EAN Head Office.
  • Where authors use generative AI and AI-assisted technologies in the writing process, these technologies should only be used to improve readability and language of the work. Applying the technology should be done with human oversight and control and authors should carefully review and edit the result, because AI can generate authoritative-sounding output that can be incorrect, incomplete, or biased. The authors are ultimately responsible and accountable for the contents of the work.
     
  • Authors should disclose the use of AI and AI-assisted technologies by ticking the relevant checkbox during the abstract submission process.
     
  • Authors should not list AI and AI-assisted technologies as an author or co-author, nor cite AI as an author. Authorship implies responsibilities and tasks that can only be attributed to and performed by humans. Authors are also responsible for ensuring that the work is original.
  • All submitted abstracts will be screened using anti-plagiarism software, then reviewed by the Ethics and Quality Task Force to determine eligibility for further consideration. Shortlisted abstracts will be evaluated by an expert panel of reviewers and the Programme Committee, who will make the final decision on inclusion in the annual EAN Congress Programme.
     
  • Only the abstract submitter will receive an email with confirmation of the abstract decision. The abstract submitter is responsible for informing all authors, co-authors, and presenters about the stage and status of the abstract.
     
  • Once an abstract is accepted, the presenting author must register for the congress. A penalty may be incurred if the presenting author, indicated at submission, does not register for congress, or does not attend the session for which (s)he has been scheduled. Not registering in time risks the omission of your accepted abstract from the Congress Programme.

FAQs

In case of any questions, head over to FAQs.

Abstract submission

Will open on Monday, 10 November 2025

Presentation Types

Abstract Topics

  1. Ageing and dementia
  2. Autonomic nervous system diseases
  3. Cerebrovascular diseases
  4. Child neurology/developmental neurology
  5. Clinical neurophysiology
  6. Cognitive neurology/neuropsychology
  7. Coma and chronic disorders of consciousness
  8. Education in neurology
  9. Environmental Neurology/Climate Change
  10. Epilepsy
  11. Ethics in neurology
  12. Headache
  13. Higher cortical functions
  14. History of neurology
  15. Infectious diseases
  16. Motor neurone diseases
  17. Movement disorders
  18. MS and related disorders
  19. Muscle and neuromuscular junction disorder
  20. Neurocritical care
  21. Neuroepidemiology
  22. Neurogenetics
  23. Neuroimaging
  24. Neuroimmunology
  25. Neuroinformatics
  26. Neurological manifestation of systemic diseases
  27. Neurology and arts
  28. Neuro-oncology
  29. Neuro-ophthalmology/ neuro-otology
  30. Neuropathies
  31. Neurorehabilitation
  32. Neurosonology
  33. Neurotoxicology/occupational neurology
  34. Neurotraumatology
  35. Pain
  36. Palliative care
  37. Peripheral nerve disorders
  38. Sleep-wake disorders
  39. Spinal cord and root disorders